1. Home
  2. OCS vs CMPR Comparison

OCS vs CMPR Comparison

Compare OCS & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • CMPR
  • Stock Information
  • Founded
  • OCS 2003
  • CMPR 1994
  • Country
  • OCS Switzerland
  • CMPR Ireland
  • Employees
  • OCS N/A
  • CMPR N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • CMPR Publishing
  • Sector
  • OCS Health Care
  • CMPR Consumer Discretionary
  • Exchange
  • OCS Nasdaq
  • CMPR Nasdaq
  • Market Cap
  • OCS 1.0B
  • CMPR 1.1B
  • IPO Year
  • OCS N/A
  • CMPR N/A
  • Fundamental
  • Price
  • OCS $19.00
  • CMPR $49.68
  • Analyst Decision
  • OCS Strong Buy
  • CMPR Strong Buy
  • Analyst Count
  • OCS 3
  • CMPR 2
  • Target Price
  • OCS $35.33
  • CMPR $62.50
  • AVG Volume (30 Days)
  • OCS 27.1K
  • CMPR 321.9K
  • Earning Date
  • OCS 08-26-2025
  • CMPR 07-30-2025
  • Dividend Yield
  • OCS N/A
  • CMPR N/A
  • EPS Growth
  • OCS N/A
  • CMPR 83.61
  • EPS
  • OCS N/A
  • CMPR 5.97
  • Revenue
  • OCS $847,333.00
  • CMPR $3,366,207,000.00
  • Revenue This Year
  • OCS $18.70
  • CMPR $4.65
  • Revenue Next Year
  • OCS $1,059.78
  • CMPR $3.16
  • P/E Ratio
  • OCS N/A
  • CMPR $8.33
  • Revenue Growth
  • OCS N/A
  • CMPR 3.64
  • 52 Week Low
  • OCS $10.79
  • CMPR $35.21
  • 52 Week High
  • OCS $23.08
  • CMPR $104.92
  • Technical
  • Relative Strength Index (RSI)
  • OCS 46.89
  • CMPR 66.92
  • Support Level
  • OCS $18.87
  • CMPR $45.78
  • Resistance Level
  • OCS $19.75
  • CMPR $50.82
  • Average True Range (ATR)
  • OCS 0.43
  • CMPR 1.96
  • MACD
  • OCS -0.11
  • CMPR 0.52
  • Stochastic Oscillator
  • OCS 32.43
  • CMPR 87.00

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About CMPR Cimpress plc (Ireland)

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

Share on Social Networks: